These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24150820)

  • 21. Impact of off-label use regulations on patient care in dermatology - a prospective study of cost-coverage applications filed by tertiary dermatology clinics throughout Germany.
    Werner RN; Pennitz A; Eisert L; Schmidle P; Zink A; Abraham S; Schäkel K; Wolff I; Goebeler M; Plange J; Sollfrank L; Zielbauer S; Koll P; Amschler K; Müller V; Nast A
    J Eur Acad Dermatol Venereol; 2022 Nov; 36(11):2241-2249. PubMed ID: 35737866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Off-label use of drugs--the legal framework].
    Koyuncu A
    Dtsch Med Wochenschr; 2012 Jul; 137(30):1519-23. PubMed ID: 22869512
    [No Abstract]   [Full Text] [Related]  

  • 24. [Off-label-use in dermatology].
    Sterry W
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):931-2. PubMed ID: 19909390
    [No Abstract]   [Full Text] [Related]  

  • 25. Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study.
    Deng S; Zhu X; Sun B; Hu J; Shang D; Chen W; Lu H; Ni X; Zhang M; Wang Z; Wen Y; Qiu C
    Int Clin Psychopharmacol; 2018 May; 33(3):172-179. PubMed ID: 29505485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Off-label use of medicine in pediatrics: focus on gastrointestinal diseases.
    Karesh A; Tomaino J; Mulberg AE
    Curr Opin Pediatr; 2013 Oct; 25(5):612-7. PubMed ID: 23995427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].
    Janzen RW; Ludwig WD;
    Z Rheumatol; 2012 Feb; 71(2):108-10, 112-8. PubMed ID: 22370801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulating off-label promotion of medications: has the pendulum swung too far?
    Hoffman MB; Yentzer BA; Feldman SR
    Skin Therapy Lett; 2015; 20(3):1-4. PubMed ID: 26382556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Research Status on Off-label Use in Appraisal for Medical Malpractice].
    Leng BN; Wang X
    Fa Yi Xue Za Zhi; 2018 Apr; 34(2):171-174. PubMed ID: 29923385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge and perception of off-label drug use amongst prescribing physicians in a tertiary care hospital.
    Kannan S; Bahl A; Khosla PP
    Int J Risk Saf Med; 2015; 27(4):219-23. PubMed ID: 26756895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Licensing and labelling of drugs in a paediatric oncology ward.
    van den Berg H; Tak N
    Br J Clin Pharmacol; 2011 Sep; 72(3):474-81. PubMed ID: 21453298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On-label and off-label prescribing patterns of erythropoiesis-stimulating agents in inpatient hospital settings in the US during the period of major regulatory changes.
    Seetasith A; Holdford D; Shah A; Patterson J
    Res Social Adm Pharm; 2017; 13(4):778-788. PubMed ID: 27595426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Criteria for good prescribing practice in children].
    Neubert A; Wimmer S
    Ther Umsch; 2014 Jun; 71(6):352-65. PubMed ID: 24867350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prescription of drugs without registered indication].
    Wetterling T
    Fortschr Neurol Psychiatr; 2004 May; 72(5):245-54. PubMed ID: 15136945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Off-label use of medical products.
    National Association Of EMS Physicians
    Prehosp Emerg Care; 2011; 15(3):419. PubMed ID: 21612389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-label prescribing in the treatment of dermatologic disease.
    Sugarman JH; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2002 Aug; 47(2):217-23. PubMed ID: 12140467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Moisturizer prescription patterns among Australasian dermatologists.
    Shumack SP; Commens CA
    Australas J Dermatol; 1988; 29(3):151-3. PubMed ID: 3272123
    [No Abstract]   [Full Text] [Related]  

  • 38. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription.
    Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC
    Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Regulatory Requirement for Patient-Specific Prescriptions for Off-Label Medications on the Use of Intravitreal Bevacizumab.
    Holfinger S; Miller AG; Rao LJ; Rowland DY; Hornik JH; Miller DG
    JAMA Ophthalmol; 2016 Jan; 134(1):45-8. PubMed ID: 26540671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.